Aethlon Medical AEMD 深 沪
等待开盘 08-21 09:30:00 美东时间
2.70
-0.080
-2.88%
华盛通- 最 高2.8714
- 今 开2.73
- 成交量 3.35万股
- 最 低 2.65
- 昨 收 2.78
- 总市值 192.01万
- 52周最高 97.50
- 市盈率 静 --
- 换手率 4.72%
- 52周最低 2.625
- 委 比 95.06%
- 总股本 71.11万
- 历史最高 2160000.00
- 量 比 0.83
- 振 幅 7.96%
- 历史最低 2.625
- 每 手 1
- 风险率 16.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.02) per share which missed the analyst consensus estimate of $(0.79) by 415.38 percent. This is a 90.52 percent increase over losses of $(42.42) per share from the same period last year.
08-14 04:17
Aethlon Medical Announces Reverse Stock Split Implementation
Aethlon Medical ( ($AEMD) ) has provided an announcement. On July 30, 2026, Aet...
07-31 20:29
Aethlon Medical Prices $4M Follow-On Offering Of 5,633,009 Shares And Warrants At $0.7101 Per Unit
Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of its follow-on offering of 5,633,009 shares of its common stock (or pre-funded warrants in lieu thereof) and warra...
07-06 21:27
Aethlon Medical Files Prospectus For Offering Mixed Shelf
https://www.sec.gov/ix?doc=/Archives/edgar/data/882291/000168316826005203/aethlon_s1a1.htm
07-01 20:49
电话会总结 ｜ Aethlon(AEMD)2026财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Aethlon Medical业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩：**现金状况：** 截至2026年3月31日，现金及现金等价物约500万美元，为持续的临床和研究活动提供资源支持。财年结束后通过市场销售计划额外筹集185万美元净收益。 **运营费用：** 2026财年运营费用约730万美元，较上年同期930万美元下降21.9%，主要得益于薪酬费用减少110万美元、一般管理费用减少50万美元、专业服务费减少40万美元。 **亏损情况：** 运营亏损从上财年的930万美元降至730万美元；归属于普通股股东的净亏损为720万美元
06-11 12:04
Aethlon Medical reports FY results
Aethlon Medical press release (AEMD):FY Net loss attributable to our common stockholders was $7.2 million for the fiscal year ended March 31, 2026, compared to net loss of $13.4 million for the fiscal...
06-11 04:23
Aethlon Medical Q4 EPS $0.40 Beats $(2.02) Estimate
Aethlon Medical (NASDAQ:AEMD) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $(2.02) by 119.9 percent. This is a 110.81 percent increase over losses of $(3.70) per share from the same period last year.
06-11 04:20
Earnings Scheduled For June 10, 2026
Companies Reporting Before The Bell • Chewy (NYSE:CHWY) is likely to report quarterly earnings at $0.39 per share on revenue of $3.35 billion. • J.Jill (NYSE:JILL) is likely to report quarterly earnings at $0.42 per share on revenue of $144.21 million. • Yuanbao (NASDAQ:YB) is estimated to report ea...
06-10 19:11
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response Efforts
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
06-06 02:24
